Skip to content

Comparison of Two Techniques of Sciatic Nerve Block With Levobupivacaine 0.5% in Orthopedic Surgery

Comparison of Two Techniques of Ultrasound-guided Sciatic Nerve Block Using Levobupivacaine 0.5% in Orthopedic Surgery at the Hospital Pablo Tobon Uribe - Clínica CES, 2013, Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01734954
Enrollment
66
Registered
2012-11-28
Start date
2013-04-30
Completion date
2013-09-30
Last updated
2013-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Keywords

Nerve block, Sciatic nerve, Ultrasonography, Orthopedics, Hallux Valgus, Amputation, Arthrodesis, Arthroscopy, Fracture fixation, Osteotomy, Tendon transfer, Tenodesis, Tenotomy, Orthopedic procedure

Brief summary

The purpose of this study is to evaluate the latency period (timing between the injection of the local anesthetic and the onset of complete sensory nerve block) of two approaches for ultrasound-guided popliteal sciatic nerve block: One of the approaches is the injection of the anesthetic just at the site of the bifurcation of the sciatic nerve and the other one is injecting the local anesthetic at least 2 cm beyond the bifurcation of the aforementioned nerve. Our main hypothesis is that the first approach will decrease the latency period, and probably, will increase the success rate of the nerve block as well as patient satisfaction.

Detailed description

Compare the effectiveness of nerve blockade at the bifurcation site of the sciatic nerve versus distal (tibial and peroneal) using only levobupivacaine 0.5%. The primary outcome is the latency period of the nerve blockade; the secondary outcomes are rate of success of the procedure as well as patient satisfaction.

Interventions

PROCEDURESciatic nerve anesthesia blockade at bifurcation.

A proximal and distal initial scan and define the site to block the bifurcation. A puncture with an insulated needle guided by ultrasound and injection of levobupivacaine circumferential in 0.5% and a total volume of 20 mL.

PROCEDURESciatic nerve blockade 2 cm beyond the bifurcation

A proximal and distal initial scan and define the sites to block: tibial and peroneal nerves separate distal 2 cm from the bifurcation site. A puncture with an insulated needle guided by ultrasound and injection of levobupivacaine circumferential in 0.5% 10 mL tibial nerve and 10 mL to the peroneal nerve.

DRUGLevobupivacaine 0.5%: 20 ml

Levobupivacaine is a local anesthetic that is commonly use for anesthesia nerve blockade.

DEVICEPortable Ultrasound Machine: Sonosite, M-Turbo, Bothell, WA

An ultrasound machine is a device that is widely used for the correct placement of the local anesthetic for anesthesia nerve blockade.

DEVICEInsulated Needle, (Stimuplex; Braun, Melsungen, Germany)

This is a specific kind of needle that is widely used for anesthesia nerve blockade.

supplemental oxygen during the block and/or during surgery

DRUGMidazolam

Intravenous midazolam for sedation during the block and/or during surgery

DRUGIntravenous analgesics

Intraoperative administration intravenous of dipyrone 30-50 mg/Kg and or intravenous ketoprofen 100 mg or diclofenac 75 mg or ketorolac 30 mg

Depending on sensitive territory committed by the type of surgery suprapatellar saphenous nerve block guided by ultrasound with 100 mm Stimuplex needle and injection of levobupivacaine 0.5% (total volume: 5 ml).

Sponsors

Hospital Pablo Tobón Uribe
CollaboratorOTHER
Clínica CES
CollaboratorUNKNOWN
CES University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for ankle or foot surgery at Hospital Pablo Tobón Uribe and Clínica CES. * Physical status classification of the American Society of Anesthesiologists (ASA) 1-3. * Age: 18-70 years. * Weight: 40-100 kg * Taller than 140 cm.

Exclusion criteria

* No patient acceptance. * Contraindications for nerve block (coagulopathy, local anesthetics allergy, sepsis, infection at the site of puncture). * Neuropathy or myopathy affecting the lower limb. * Psychiatric or neurological diseases that alter the evaluation of patient. * Arrhythmias. * Heart failure. * Diabetes Mellitus. * Pregnancy. * Language barriers. * Anticoagulation.

Design outcomes

Primary

MeasureTime frameDescription
Latency period of sciatic nerve block.5 minutes, 10 minutes, 15 minutes, 20 minutes, 25 minutes and 30 minutes after nerve block.Once the nerve blockade is done, a sensory evaluation will be performed in the surgical area every five minutes to determine the onset of the sensory nerve blockade in minutes.

Secondary

MeasureTime frameDescription
Patient satisfactionPostoperative 24 hoursUsing a categorical score we will measure satisfaction of nerve-block-procedure satisfaction and analgesia quality one day after surgery: patients will choose one of three options: no satisfied, satisfied or very satisfied.
Sensory block5, 10, 15, 20, 25 and 30 minutes after the block is finishedEvaluation in 5, 10, 15, 20, 25 and 30 minutes after the procedure in the distribution of the common peroneal and tibial nerves 0: Complete sensory block 1. Almost complete sensory block: Decreased sensation to pinprick with a 24 gauge hypodermic needle 2. Feeling normal (for each component: tibial and common peroneal) compared with the contralateral leg
Motor block5, 10, 15, 20, 25 and 30 minutes of completion after the block is finishedEvaluation in 5, 10, 15, 20, 25 and 30 minutes after the procedure in the distribution of the common peroneal and tibial nerves 0: Complete motor blockade 1. Motor block almost complete 2. No motor block (for the tibial component for plantarflexion and dorsiflexion with the common peroneal) compared with the contralateral leg
First analgesic5 minutes, 30 minutes, 24 hours postoperativeTime of first analgesic requirement in postoperative
Visual analog scale at rest5 minutes, 30 minutes, 24 hours postoperativePain rating ranging from zero to ten VAS 0: no pain VAS 1-3: Mild pain VAS 4-6: Moderate Pain VAS 7-10: Severe pain
Dynamic visual analog scale5 minutes, 30 minutes, 24 hours postoperativePain rating ranging from zero to ten with the movement
Intraneural injectionAt the time of injection and execution of the blockIncreased diameter nerve or visualized by ultrasound visualization of the needle into the nerve at the time of injection
Vascular punctureDuring the execution of the blockPuncture of one or more blood vessels to visualize the needle within the vessel or to aspirate blood during block
Success of sciatic nerve blockEvery 5 minutes until 30 minutes until the end of the procedure for the nerve block; an additional measure will be performed at the end of of the surgery.The time to achieve a complete sensory nerve block, reached maximum at 30 minutes, in full distribution of tibial nerve and common fibular nerve for anesthesia.
Systemic toxicity of local anestheticsDuring the execution of the block and 30 minutes after itSystemic toxicity of local anesthetics
HematomaDuring and inmmediately after the execution of the blockHematoma
Muscle weakness24 hours postoperativeSubjective reduction in muscle strength at 24 hours postoperative
Altered sensitivity24 hours postoperativeSubjective decreased sensitivity at 24 hours postoperative
Cramps postoperative24 hours postoperative of the blockFeeling cramps within 24 hours of the block
PuncturesDuring the blockNumber of skin punctures during the block
Time for the execution of nerve blockIn minutes: Time from placement of the transducer for the initial scan to final withdrawal of the needleTime from placement of the transducer for the initial scan to final withdrawal of the needle
Paresthesia during the procedureAt the time of the execution of the blockParesthesia during the procedure

Countries

Colombia

Contacts

Primary ContactMarta I Berrio, MD
martaberrio@gmail.com+57 301 4839308
Backup ContactJuan-Felipe Vargas, MD
vargasj@une.net.co+57 311 6306919

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026